• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, September 11, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Anti-Angiogenesis Drug Discovery and Development, now in its 4th edition

Bioengineer by Bioengineer
July 16, 2019
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Bentham Science ongoing book series continues to bring more updates anti-angiogenesis drug targets.

This volume brings together 7 reviews on the following topics: Retinal angiogenesis in diabetes and macular degenerative processes; the effects of brief daily EMF therapy on tumor growths in hypoxia induced cancers in mice; reviews of anti-angiogenic cancer treatments over the last few decades; anti-angiogenic therapies for multiple sclerosis; and an update on the link between angiogenesis and portal hypertension. The volume is interesting reading for pharmacologists and clinicians interested in the role of angiogenesis and associated treatments in oncology, ophthalmology and neurology.

###

About The Editors:

Atta-ur-Rahman, Ph.D. in organic chemistry from Cambridge University (1968), has 1142 international publications in several fields of organic chemistry including 775 research publications, 43 international patents, 70 chapters in books and 256 books published largely by major U.S. and European presses. He is the Editor-in-Chief of eight European Chemistry journals. He is Editor of the world’s leading encyclopedic series of volumes on natural products “Studies in Natural Product Chemistry” 60 volumes of which have been published under his Editorship by Elsevier during the last two decades.

M. Iqbal Choudhary is a Ph. D. scientist in the field of organic chemistry from Pakistan working at the University of Karachi. He is known for his research in bioorganic chemistry and natural product chemistry. He has more than 900 research publications, including 33 books published.

For further Information, Please visit : https://ebooks.benthamscience.com/book/9781681083971/

Media Contact
Faizan ul Haq
[email protected]

Tags: Breast CancercancerGastroenterologyMedicine/Health
Share12Tweet7Share2ShareShareShare1

Related Posts

Poly-L-Histidine-Coated Nanoparticles for Targeted Doxorubicin Delivery

September 11, 2025

Barriers to Video Visits for Non-English Patients

September 11, 2025

Smart ROS Nanoplatform Boosts Targeted Cancer Therapy

September 11, 2025

Creating AI Companions for Caregiver Role Transitions

September 11, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    64 shares
    Share 26 Tweet 16
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Poly-L-Histidine-Coated Nanoparticles for Targeted Doxorubicin Delivery

Revolutionary Ion Exchange Membranes for Arsenic Removal

PATZ1: Key Player in Tumorigenesis and Metabolism

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.